VTRVentas

$82.04+23% 1Y

VTR in its own filings

VTR's filing record carries 3 kinds of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.

706

Events found in the filings · across 3,609 filings · the record starts in 1995

Hard flags
3

Hard flags

Most recent filing
Sep 15, 2026

Most recent filing · Form 8-K

Record starts
Mar 30, 1995

Record starts · the earliest filing Ryufin holds for this name

Details›
Next results filingsame week as a year ago
expected around Oct 28, 2026
Restatement admitted (non-reliance)historical
2014-07-09
Change in certifying accountant2 occurrences
2014-07-11
Late periodic reporthistorical
2001-04-02
Security removed from listing or deregistered2 occurrences · usually a matured note or preferred class, not the common shares
2019-01-04
SEC comment-letter activity56 occurrences
2022-03-15

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

What the company said

The company's own words from its current reports to the SEC, newest first

  1. Sep 15, 2026On September 10, 2026, Ventas, Inc. (the “Company”) approved the appointment of Laurida Sayed as its Senior Vice President, Chief Accounting Officer and Controller of the Company, effective on or around October 5, 2026 (the “Effective Date”)Director or officer change · Form 8-K
  2. Jun 15, 2026On June 15, 2026, Carey S. Roberts, Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary of Ventas, Inc. (“Ventas” or the “Company”) notified Ventas of her intention to resign from the Company effective June 26, 2026 (the “Effective Date”)Director or officer change · Form 8-K
  3. May 15, 2026On May 12, 2026, in connection with his previously disclosed retirement on May 1, 2026, Ventas, Inc. (the “Company”) entered into a separation and release agreement with Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services …Director or officer change · Form 8-K
  4. Feb 20, 2026On February 16, 2026, Gregory R. Liebbe, Senior Vice President, Chief Accounting Officer and Controller informed Ventas, Inc. (the “Company”) that he is resigning to pursue other opportunities.Director or officer change · Form 8-K
  5. Feb 9, 2026On February 9, 2026, Ventas, Inc. (the “Company”) entered into Amendment No. 2 (“Amendment No. 2”) to the ATM Sales Agreement, dated September 18, 2024 (the “Original Agreement”), as amended by that Amendment No. 1 to the ATM Sales Agreement, dated June 13, 2025 (“Amendment No. 1” and together with the Original …Other event · Form 8-K
  6. Jan 7, 2026On January 7, 2026, Ventas Realty, Limited Partnership (the “Borrower”), a wholly owned subsidiary of Ventas, Inc. (the “Company”), and the Company, as guarantor, entered into an amendment to the Credit Agreement (as defined below) (the “Amendment”) with the lenders identified therein and Bank of America, N.A., as …Material agreement entered · Form 8-K
  7. Dec 4, 2025On December 4, 2025, Ventas Realty, Limited Partnership (“Ventas Realty”), a wholly owned subsidiary of Ventas, Inc. (the “Company”), issued and sold $500,000,000 in aggregate principal amount of its 5.000% Senior Notes due 2036 (the “Notes”) in a registered public offering pursuant to the existing registration …Other event · Form 8-K
  8. Nov 17, 2025On November 17, 2025, Ventas, Inc. (the “Company”) announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc., is expected to retire effective as of May 1, 2026 (the “Effective Date”)Director or officer change · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.

opening the record…